beta-Lactam MICs correlate poorly with mutant prevention concentrations for clinical isolates of Acinetobacter spp. and Pseudomonas aeruginosa
about
Pharmacokinetics of Continuous Infusion Meropenem With Concurrent Extracorporeal Life Support and Continuous Renal Replacement Therapy: A Case Report.Therapeutic Drug Monitoring of Continuous Infusion Doripenem in a Pediatric Patient on Continuous Renal Replacement Therapy.A model-based analysis of the predictive performance of different renal function markers for cefepime clearance in the ICU.DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
P2860
beta-Lactam MICs correlate poorly with mutant prevention concentrations for clinical isolates of Acinetobacter spp. and Pseudomonas aeruginosa
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
beta-Lactam MICs correlate poo ...... pp. and Pseudomonas aeruginosa
@en
beta-Lactam MICs correlate poo ...... pp. and Pseudomonas aeruginosa
@nl
type
label
beta-Lactam MICs correlate poo ...... pp. and Pseudomonas aeruginosa
@en
beta-Lactam MICs correlate poo ...... pp. and Pseudomonas aeruginosa
@nl
prefLabel
beta-Lactam MICs correlate poo ...... pp. and Pseudomonas aeruginosa
@en
beta-Lactam MICs correlate poo ...... pp. and Pseudomonas aeruginosa
@nl
P2093
P2860
P356
P1476
beta-Lactam MICs correlate poo ...... pp. and Pseudomonas aeruginosa
@en
P2093
Andrea Dos Santos Pereira
Antônio C C Pignatari
Juliana Gugel
P2860
P304
P356
10.1128/AAC.00144-06
P407
P50
P577
2006-06-01T00:00:00Z